Cardiff Oncology (CRDF) delivered earnings and revenue surprises of 19.23% and 108%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
DEER PARK, Ill., Feb. 29, 2024 Eton Pharmaceuticals, Inc. , an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it.
Paradigm Capital Management Inc NY Acquires New Position in Harrow Health, Inc (NASDAQ:HROW) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Eton Cares patient support program offers $0 co-pay to eligible, commercially insured patients Current Nitisinone market is estimated to exceed $50 million annually Product is now.